PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
AMBP 160 Target Target AFP 9,751 1 0.00 -1.00 0.01 0.59
AMAC-1 19 Target Target CCL3 1,427 1 0.01 -0.97 0.05 0.68
AMAC-1 19 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -0.97 0.05 0.58
AMAC-1 19 Target Disease Arthritis 128,324 1 0.00 -0.97 0.05 0.57
AMAC-1 19 Target Target Eotaxin 2,457 1 0.00 -0.97 0.05 0.66
AMAC-1 19 Target Target CCL2 3,560 1 0.00 -0.97 0.05 0.65
AMAC-1 19 Target Target CD14 9,941 1 0.00 -0.97 0.05 0.63
AMAC-1 19 Target Target CCL4 5,638 1 0.00 -0.97 0.05 0.64
AMAC-1 19 Target Target CCL18 256 4 0.06 -0.88 0.21 0.79
AMAC-1 19 Target Disease Cancer 1,053,491 1 0.00 -0.97 0.05 0.53
AMAC-1 19 Target Disease Osteoarthritis 36,287 1 0.00 -0.97 0.05 0.60
AMAC-1 19 Target Disease Inflammation 252,734 5 0.00 -0.86 0.26 0.59
AMAC-1 19 Target Disease Septic Arthritis 4,121 1 0.00 -0.97 0.05 0.65
AMAC-1 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53
AMAC-1 19 Target Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
AMAC-1 19 Target Target DC-CK1 22 4 0.20 -0.80 0.21 0.90
ALPP 80 Target Target Collagen 138,882 2 0.00 -0.99 0.03 0.56
ALPP 80 Target Disease Pain 409,851 2 0.00 -0.99 0.03 0.53
ALPP 80 Target Disease Infertility 35,448 1 0.00 -0.99 0.01 0.57
ALPP 80 Target Disease Menopause 19,680 1 0.00 -0.99 0.01 0.59
ALPP 80 Target Disease Disabilities 28,757 1 0.00 -0.99 0.01 0.58
ALK Phos 19 Target Disease Cholesterol 182,390 3 0.00 -0.92 0.16 0.58
ALK Phos 19 Target Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
ALK Phos 19 Target Disease Liver Disease 49,817 1 0.00 -0.97 0.05 0.59
ALK Phos 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
ALK Phos 19 Target Disease Skin Rash 3,684 1 0.00 -0.97 0.05 0.65
ALK Phos 19 Target Target CD146 729 1 0.01 -0.97 0.05 0.70
ALK Phos 19 Target Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
ALK Phos 19 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
ALK Phos 19 Target Disease Hepatitis 163,842 1 0.00 -0.97 0.05 0.56
AKT3 293 Target Disease Mesothelioma 11,198 1 0.00 -1.00 0.00 0.58
AKT3 293 Target Disease Glioblastoma 17,933 6 0.00 -0.99 0.02 0.61
AKT3 293 Target Disease Inflammation 252,734 6 0.00 -0.99 0.02 0.54
AKT3 293 Target Drug Doxorubicin 28,033 3 0.00 -0.99 0.01 0.58
AKT3 293 Target Disease Liver Disease 49,817 1 0.00 -1.00 0.00 0.54
AKT3 293 Target Disease Brain Tumors 16,749 1 0.00 -1.00 0.00 0.57
AKT3 293 Target Target ERBB3 1,154 3 0.01 -0.99 0.01 0.68
AKT3 293 Target Target Glutathione S-Transferase Mu 2 8 1 0.02 -0.93 0.12 0.74
AKT3 293 Target Disease Pain 409,851 1 0.00 -1.00 0.00 0.50
AKT3 293 Target Target APOE 12,771 1 0.00 -1.00 0.00 0.57
AKT3 293 Target Disease Epilepsy 71,172 4 0.00 -0.99 0.01 0.57
AKT3 293 Target Disease Sarcoidosis 19,176 1 0.00 -1.00 0.00 0.56
AKT3 293 Target Disease Seizures 66,465 5 0.00 -0.99 0.02 0.57
AKT3 293 Target Disease Salivary Gland Cancer 202 1 0.00 -1.00 0.00 0.70
AKT3 293 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -1.00 0.00 0.53
AKT3 293 Target Disease Cholesterol 182,390 1 0.00 -1.00 0.00 0.51
AKT3 293 Target Target Collagen 138,882 6 0.00 -0.99 0.02 0.56
AKT3 293 Target Disease Hepatitis 163,842 1 0.00 -1.00 0.00 0.51
AKT3 293 Target Target Cox-2 21,583 1 0.00 -1.00 0.00 0.56
AKT3 293 Target Target ERK2 3,287 2 0.00 -1.00 0.01 0.63